Bromantane Chemical Identity: Reading Names, Formulae, and Structure Records

A clear identity record is the foundation of a laboratory documentation file. This article explains how to assemble one for bromantane while keeping reference information separate from sample-specific evidence.

Start with an authoritative structure record

The FDA Global Substance Registration System record for bromantane lists the molecular formula C16H20BrN and provides machine-readable structural identifiers. It also records bromantan as a name variant. These are identity data, not an endorsement of a commercial product.

The CFSRE bromantane monograph gives the structural name N-(4-bromophenyl)adamantan-2-amine. Use the linked record when checking how the name relates to the structure, rather than relying on a shortened marketing description.

For your own file, preserve the source URL and the date consulted alongside the chosen name. If you copy a structural identifier into a database, keep it exact; do not edit punctuation or character case to make it more readable.

A practical record might include the common name, source-backed structure designation, database reference, and supplier product name. Keep a separate field for the batch identifier. This prevents a database entry from being mistaken for a sample record.

The purpose of the identity record is narrower: to make clear which chemical entity the documentation intends to describe and where that description came from.

Keep this reference entry separate from receiving records so later updates do not erase the history of a supplied batch.

Distinguish formula information from full identification

A molecular formula is useful shorthand, but an identity review should not stop there. In a practical documentation workflow, retain the structural record and the name together rather than reducing the file to a formula alone.

For bromantane, write the formula exactly as supported by the source. Keep mass-related fields under their original labels. If one document reports molecular weight and another reports an ion measurement, do not silently treat those fields as interchangeable.

This article does not supply a mass-spectrometric acceptance window or a laboratory identification rule. Those choices belong in an appropriate method and its supporting documentation. The role of a shop article is to explain the questions, not to invent a test.

A useful review table is:

Treat an inconsistency as something to investigate. It may be a transcription issue, a difference in naming convention, or a more substantive problem; the document alone may not tell you which.

Avoid resolving mismatches by choosing the value that looks most familiar. Preserve both original entries and document the clarification that supports any later correction.

Connect the reference record to supplier documentation

Once the intended identity is recorded, examine how the supplier describes the material. Match the product designation to the applicable documents and identify the batch reference. Do not assume that a general product sheet and a batch-specific report have the same evidentiary role.

For example, a product sheet may state the chemical name while an analytical report addresses a submitted sample. Your review should explain how the submitted sample relates to the supplied batch. If that link is absent, keep the gap visible.

Ask focused questions when requesting documentation. “Which batch does this report concern?” is easier to answer than “Is this high quality?” Similarly, a request for the method reference is more concrete than a request for reassurance.

Keep copies of the actual documents used for the decision. A changing webpage may be useful for discovery, but a project file should identify the information relied on at the time of review. Record updates as updates instead of overwriting the earlier reasoning.

This distinction helps purchasing staff and laboratory staff communicate without expecting a chemical database to answer a question about a physical container. It also prevents an ordinary catalog description from acquiring unsupported analytical meaning.

Write conclusions that stay within the evidence

A good identity summary uses precise verbs. A database “lists” a formula. A supplier “identifies” a product. A laboratory “reports” a result for a sample. These formulations make the source of each statement visible.

Avoid writing “bromantane is verified” without explaining what was verified, by whom, and for which material. The statement is too broad to be useful in a technical file. A narrower conclusion can still support a purchasing or research decision if its limits are understood.

For a simple internal review, finish with three statements: the intended chemical identity, the documents connecting it to the supplied material, and any remaining analytical questions. Where evidence is missing, say so directly. This is preferable to borrowing confidence from an authoritative database.

The bromantane analytical-evidence article discusses a different question: how to read analytical evidence without treating a signal as a complete characterization.

You can consult Bromantane for the relevant catalog entry. This article does not state that any NOOROLABS batch is certified, independently verified, or suitable as a reference standard.

Reference information defines the question; sample evidence answers it. Keeping those roles distinct makes the final record easier to review and update when additional documentation becomes available.